Tretten 2500 Unit (Catridecacog POWDER FOR SOLUTION) 2500 UNIT

TRETTEN 2500 UNIT is a powder for solution containing Catridecacog, used for intravenous administration. It is designed to manage certain medical conditions related to blood clotting. This product is manufactured by Novo Nordisk Canada Inc.

Strength

2500 UNIT

Pack Size

2500IU

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRETTEN 2500 UNIT, containing the active ingredient Catridecacog, is generally used to address conditions related to blood clotting. It is often prescribed for individuals who require support in managing bleeding episodes. The primary use of Catridecacog is to help control bleeding in patients with certain clotting disorders. This medication is administered intravenously and is designed to provide rapid relief in emergency situations.

Side Effects

When administered, TRETTEN 2500 UNIT may help to control bleeding by supporting the body's natural clotting process. Patients often experience a reduction in bleeding episodes and improved clotting function. The effects of Catridecacog are typically observed shortly after administration, providing quick relief in critical situations.

Precautions & Warnings

TRETTEN 2500 UNIT should be handled with care and administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration instructions to avoid potential complications. Patients with known allergies to Catridecacog or any of the ingredients should avoid using this medication. Always consult a healthcare provider before starting any new treatment.

Avoid Interactions

TRETTEN 2500 UNIT may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of Catridecacog, so it is advisable to discuss any dietary or lifestyle changes with your healthcare provider.

Frequently Asked Questions

TRETTEN 2500 UNIT is used to manage bleeding episodes in patients with certain clotting disorders.

TRETTEN 2500 UNIT is administered intravenously as a powder for solution.

Common effects include improved clotting function and reduced bleeding episodes.

Yes, it should be administered under healthcare supervision and avoided by those allergic to Catridecacog.

Yes, it may interact with medications that affect blood clotting, so consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.